Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Intermittent Claudication: early-phase trial registry
3 of 12 indexed Intermittent Claudication trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,429 of 28,707 conditions by registered trial count.
12 US clinical trials · 3 currently recruiting · #1,429 of 28,707 conditions by registered trial count
Intermittent Claudication: 12 US clinical trials tracked, 3 recruiting.
Intermittent Claudication is the subject of 12 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is Northwestern University, running 2 of these trials.
Enrollment posture brief
Registry condition intermittent-claudication
OPEN 3 | RECR 25% | LATE 2 | EARLY 5 | RANK #1429 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)
Intermittent Claudication lists 3 open slots (25% of 12 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Intermittent Claudication on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Intermittent Claudication is recruiting below its size-band peers.
3 of 12 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Intermittent Claudication research.
Northwestern University accounts for 2 of 12 trials (16.7%). 11 distinct sponsors appear on at least one study for this condition label.
-
Typical Intermittent Claudication enrolment sits around 200 participants.
Median target enrolment is 200 among the 12 trials that report a genuine target (sentinel values excluded). 4 of those (33.3%) plan for fewer than 100 participants.
-
Intermittent Claudication research is mostly interventional.
11 interventional and 1 observational studies make up this index (91.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
12 total, page 1 of 1
Improving Mobility After Revascularization in Peripheral Artery Disease
Northwestern University
NCT06686121
Response to Exercise and Nitric Oxide in PAD
Northwestern University
NCT06657976
MetfOrmin BenefIts Lower Extremities With Intermittent Claudication
VA Office of Research and Development
NCT05132439
The Chocolate Touch Study
TriReme Medical
NCT02924857
Efficacy and Safety of HMR1766 in Patients With Fontaine Stage II Peripheral Arterial Disease
Sanofi
NCT00443287
Safety and Efficacy Study of Ad2/Hypoxia Inducible Factor (HIF)-1α/VP16 Gene Transfer in Patients With Intermittent Claudication
Genzyme, a Sanofi Company
NCT00117650
A Phase 2 Study of the Effects of Sapropterin Dihydrochloride on Symptomatic Peripheral Arterial Disease
BioMarin Pharmaceutical
NCT00403494
Distributed Registry
Stanford University
NCT03898570
Exercise Training for Patients With Poor Leg Circulation
US Department of Veterans Affairs
NCT00118560
Bioequivalency Study of 100 mg Cilostazol Tablets Under Fasting Conditions
Roxane Laboratories
NCT00602173
Ischemic Preconditioning Claudication Study
Medical College of Wisconsin
NCT03511157
Pharmacokinetic Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
Genovate Biotechnology Co., Ltd.,
NCT03480321
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 4 |
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Intermittent Claudication records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Intermittent Claudication trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Intermittent Claudication page
12 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Intermittent Claudication trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Northwestern University sponsors the most Intermittent Claudication trials on record, review their full trial history before evaluating a specific study. See Northwestern University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Intermittent Claudication condition card totals 12 registered trials; most-linked intervention placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.